![](/images/graphics-bg.png)
Gastrointestinal complications of ferrous sulfate in pregnant women : a randomized double-blind placebo-controlled trial
المؤلفون المشاركون
begloo, Ismat Jafar
Tihran, Huda Ahmari
Tehrani, Tahmineh Dadkhah
المصدر
Iranian Red Crescent Medical Journal
العدد
المجلد 17، العدد 8 (31 أغسطس/آب 2015)، ص ص. 1-5، 5ص.
الناشر
تاريخ النشر
2015-08-31
دولة النشر
الإمارات العربية المتحدة
عدد الصفحات
5
التخصصات الرئيسية
الموضوعات
الملخص EN
Background : Some pregnant women discontinue iron supplements consumption due to Gastrointestinal (GI) complications, whereas pregnancy induces the same complications physiologically.
Objectives : The aim of the present study was to assess GI complications of ferrous sulfate in pregnant women.
Patients and Methods : This randomized, double-blind, placebo-controlled clinical trial was performed on 176 pregnant women referred to prenatal care clinic of Maryam Hospital from April 2011 to February 2012.
Pregnant women with Hb ≥ 13.2 gr/dL at 13th - 18th weeks of gestation were selected based on the inclusion criteria and were randomly assigned to the ferrous sulfate and placebo groups.
The ferrous sulfate group (n = 90) received a 50-mg ferrous sulfate tablet daily from the 20th week to the end of pregnancy and the placebo group (n = 89) received one placebo tablet in the same way.
All participants were visited twice at 24th - 28th and 32nd - 36th weeks to assess the GI complications as well as Hb level to determine the Hb changes in two groups.
Chi-square test, t-test and Kolmogorov-Smirnov test were used to analyze the data.
P value of < 0.05 and confidence level of 95% were considered as statistically significant.
Results : None of the GI complications were significantly different between the ferrous sulfate and placebo groups at 24th - 28th and 32nd - 36th weeks.
Hemoglobin drop lower than 10.5 gr/dL at 24th - 28th weeks or lower than 11 g/dL at 32nd - 36th weeks was not observed in any cases.
Conclusions : It can be concluded that GI complications in pregnant women using ferrous sulfate are mostly caused by physiologic changes of pregnancy rather than ferrous sulfate; therefore, it is not reasonable to stop using ferrous sulfate due to GI complications.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
begloo, Ismat Jafar& Tihran, Huda Ahmari& Tehrani, Tahmineh Dadkhah. 2015. Gastrointestinal complications of ferrous sulfate in pregnant women : a randomized double-blind placebo-controlled trial. Iranian Red Crescent Medical Journal،Vol. 17, no. 8, pp.1-5.
https://search.emarefa.net/detail/BIM-605921
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
begloo, Ismat Jafar…[et al.]. Gastrointestinal complications of ferrous sulfate in pregnant women : a randomized double-blind placebo-controlled trial. Iranian Red Crescent Medical Journal Vol. 17, no. 8 (Aug. 2015), pp.1-5.
https://search.emarefa.net/detail/BIM-605921
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
begloo, Ismat Jafar& Tihran, Huda Ahmari& Tehrani, Tahmineh Dadkhah. Gastrointestinal complications of ferrous sulfate in pregnant women : a randomized double-blind placebo-controlled trial. Iranian Red Crescent Medical Journal. 2015. Vol. 17, no. 8, pp.1-5.
https://search.emarefa.net/detail/BIM-605921
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 5
رقم السجل
BIM-605921
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)